|Articles|December 7, 2011
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-12-07-2011
- Volume 7
- Issue 12
Technical Perspectives: Antibody Drug Conjugates
Author(s)Patricia Van Arnum
A podcast moderated by Patricia Van Arnum, executive editor of Pharmaceutical Technology.
Advertisement
Antibody drug conjugates represent a niche area of drug development. Antibody drug conjugates combine a small-molecule, often a cytotoxic compound, to a monoclonal antibody. Grant E. Boldt, PhD, director of European business development for SAFC, discusses manufacturing considerations in producing antibody drug conjugates with Patricia Van Arnum, executive editor of Pharmaceutical Technology. Listen to the
Articles in this issue
over 14 years ago
CSR and Sustainability in the Newsover 14 years ago
Pharmaceutical Companies Target Green Manufacturingover 14 years ago
Biosimilars' Technology NeedsAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
CAR T-Cell Trial Pause Signals New Manufacturing Risk Review
2
Application of Predictive Modeling in the Development of Amorphous Solid Dispersions
3
AAPS PharmSci 360: CMC Strategies, Part 1
4
What Novartis's $3.2 Billion Enzyme Licensing Deal Means for Formulation
5